thiazoles has been researched along with perazine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beszlej, A; Bieńkowski, P; Frydecka, D; Grzywacz, A; Mak, M; Mierzejewski, P; Potemkowski, A; Samochowiec, A; Samochowiec, J; Tybura, P | 1 |
| Beszlej, A; Bienkowski, P; Frydecka, D; Grzywacz, A; Mierzejewski, P; Samochowiec, A; Samochowiec, J; Trześniowska-Drukała, B; Tybura, P | 1 |
2 trial(s) available for thiazoles and perazine
| Article | Year |
|---|---|
Some dopaminergic genes polymorphisms are not associated with response to antipsychotic drugs in schizophrenic patients.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Dopamine; Dopamine Antagonists; Female; Follow-Up Studies; Genotype; Humans; Male; Middle Aged; Olanzapine; Perazine; Piperazines; Polymorphism, Genetic; Schizophrenia, Paranoid; Thiazoles; Time Factors; Treatment Outcome; Young Adult | 2012 |
Pharmacogenetics of adverse events in schizophrenia treatment: comparison study of ziprasidone, olanzapine and perazine.
Topics: Adult; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Catechol O-Methyltransferase; Dopamine Plasma Membrane Transport Proteins; Female; Genotype; GluK3 Kainate Receptor; Humans; Male; Middle Aged; Monoamine Oxidase; Olanzapine; Overweight; Perazine; Piperazines; Polymorphism, Genetic; Receptor, Serotonin, 5-HT2A; Receptors, Dopamine D2; Receptors, Kainic Acid; Schizophrenia, Paranoid; Serotonin Plasma Membrane Transport Proteins; Thiazoles; Weight Gain; Young Adult | 2014 |